Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Oncology Research and Treatment

Vol. 40, No. 11, 2017

Issue release date: October 2017

Add all to MyReading List
 
645

Editorial Board / Contents / Imprint

Oncol Res Treat 2017;40:645-650 (DOI:10.1159/000484306)
Free Access
Editorial
652

Immune Therapy of Lympho-Hemopoietic Malignancies

Echchannaoui H. · Theobald M.
Oncol Res Treat 2017;40:652-653 (DOI:10.1159/000484052)
Free Access
Review Article
654

Checkpoint Inhibition in Hodgkin Lymphoma - a Review

Bröckelmann P.J. · Engert A.
Oncol Res Treat 2017;40:654-660 (DOI:10.1159/000481800)
662

Checkpoint Inhibition in Non-Hodgkin's Lymphoma

Heß G.
Oncol Res Treat 2017;40:662-672 (DOI:10.1159/000481888)
674

Cellular Immunotherapy in B-Cell Malignancy

Schwarzbich M.-A. · Witzens-Harig M.
Oncol Res Treat 2017;40:674-681 (DOI:10.1159/000481946)
682

Wilms' Tumor Gene 1 (WT1) Peptide Vaccine Therapy for Hematological Malignancies: From CTL Epitope Identification to Recent Progress in Clinical Studies Including a Cure-Oriented Strategy

Oka Y. · Tsuboi A. · Nakata J. · Nishida S. · Hosen N. · Kumanogoh A. · Oji Y. · Sugiyama H.
Oncol Res Treat 2017;40:682-690 (DOI:10.1159/000481353)
Editor's Choice - Free Access
691

Specific Adoptive Cellular Immunotherapy in Allogeneic Stem Cell Transplantation

Audehm S. · Krackhardt A.M.
Oncol Res Treat 2017;40:691-696 (DOI:10.1159/000484051)
Original Article
697

Definitive Radiotherapy for Primary Squamous Cell Carcinoma of the Vagina: Are High-Dose External Beam Radiotherapy and High-Dose-Rate Brachytherapy Boost the Best Treatment? Experience of Two Italian Institutes

Laliscia C. · Gadducci A. · Fabrini M.G. · Barcellini A. · Guerrieri M.E. · Parietti E. · Ursino S. · Morganti R. · Cafaro I. · Paiar F.
Oncol Res Treat 2017;40:697-701 (DOI:10.1159/000480350)
702

Evidence for an Association of ERCC1 Expression and Mismatch Repair Status with Overall Survival in Colorectal Cancer Patients

Li P. · Xiao Z.-T. · Braciak T.A. · Ou Q.-J. · Chen G. · Oduncu F.S.
Oncol Res Treat 2017;40:702-706 (DOI:10.1159/000479068)
707

Circulating Cell-Free DNA Levels in Patients with Metastatic Renal Cell Carcinoma

Rouvinov K. · Mermershtain W. · Dresler H. · Ariad S. · Riff R. · Shani-Shrem N. · Keizman D. · Douvdevani A.
Oncol Res Treat 2017;40:707-710 (DOI:10.1159/000479523)
 
711

Society Bulletins

Oncol Res Treat 2017;40:711-717 (DOI:10.1159/000484125)
PharmaForum
719

Rezidivrisiko langfristig minimiert

Oncol Res Treat 2017;40:719 (DOI:10.1159/000484307)
MyKarger login required
Free Access
721

5 Jahre Erfahrung mit dem 5-Tages-Regime

Oncol Res Treat 2017;40:721 (DOI:10.1159/000484308)
MyKarger login required
Free Access
 
723

PharmaNews

Oncol Res Treat 2017;40:723 (DOI:10.1159/000484309)
MyKarger login required
Free Access
724

PharmaNews

Oncol Res Treat 2017;40:724-725 (DOI:10.1159/000484310)
MyKarger login required
Free Access
726

PharmaNews

Oncol Res Treat 2017;40:726-727 (DOI:10.1159/000484311)
MyKarger login required
Free Access
729

Meetings and Conferences

Oncol Res Treat 2017;40:729-732 (DOI:10.1159/000484124)
Free Access